dm+d

108965009

Refrigerated Storage

NeupogenAmgen Ltd

Amgen Ltd
Neupogen
Solution for injection: 30 MU vials; 30 MU and 48 MU Singleject pre-filled syringes

Contact Amgen Ltd in all cases where a deviation from the recommended storage conditions has occurred. Refer to the current BNF for company contact details.

Accidental exposure to freezing temperatures does not adversely affect the stability of Neupogen.

Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk

15 March 2021
London MI Service

Zarzio®Sandoz

Sandoz
Zarzio®
30 MU/0.5 ml and 48 MU/0.5 ml solution for injection or infusion in pre-filled syringes

In the event of an inadvertent temperature excursion the following data may be used:
Within its shelf-life and for the purpose of ambulatory use, the patient may remove the product from the refrigerator and store it at room temperature (not above 25°C) for one single period of up to 72 hours. At the end of this period, the product should not be put back in the refrigerator and should be disposed of.

Contact Sandoz Limited in all cases where a deviation from the recommended storage conditions has occurred.
Refer to the electronic medicines compendium (eMC) at www.medicines.org.uk/emc/ for company contact details

See above
No
14 October 2022
London MI Service

NivestimHospira UK Ltd (part of Pfizer)

Hospira UK Ltd (part of Pfizer)
Nivestim
12 MU/0.2ml, 30 MU/0.5ml, 48 MU/0.5ml pre-filled syringe

In the event of an inadvertent temperature excursion the following data may be used:
Within its shelf-life and for the purpose of ambulatory use, the product may be removed from the refrigerator and stored at room temperature (not above 25°C) for one single period of up to 15 days. At the end of this period, the product should not be put back in the refrigerator and should be disposed of.
Accidental exposure to freezing temperatures for up to 24 hours does not affect the stability of Nivestim. The frozen pre-filled syringes can be thawed and then refrigerated for future use. If exposure has been greater than 24 hours or frozen more than once, then Nivestim should not be used.
Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk

Reduce the expiry date to 15 days as above.
No, if exposed to the conditions above
12 October 2021
London MI Service

Lactation Safety Information

Unglycosylated recombinant human granulocyte-colony stimulating factor; rhG-CSF

Unglycosylated recombinant human granulocyte-colony stimulating factor; rhG-CSF
Yes
Limited published evidence of safety
Low levels anticipated in milk due to the drug's properties which are unlikley to be absorbed from the infants GI tract
Used in full-term neonates from birth
G-CSF is a normal component of breast milk
16 September 2019